Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study

BACKGROUND: To investigate the effects of dipeptidyl peptidase-4 inhibitor (DPP4i) as add-on medications to metformin on progression of diabetic retinopathy (DR) in patients with type 2 diabetes mellitus, compared with sulfonylurea (SU) or thiazolidinedione (TZD). METHODS: We identified 4,447 patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Yoo-Ri, Ha, Kyoung Hwa, Kim, Hyeon Chang, Park, Sang Jun, Lee, Kihwang, Kim, Dae Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834833/
https://www.ncbi.nlm.nih.gov/pubmed/30877707
http://dx.doi.org/10.4093/dmj.2018.0137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834833/
https://www.ncbi.nlm.nih.gov/pubmed/30877707
http://dx.doi.org/10.4093/dmj.2018.0137

Ejemplares similares